Remote Therapeutic Monitoring (RTM) & EllieGrid

Make $143/Month/Patient Via RTM

Remote Therapeutic Monitoring (RTM) is designed to help healthcare providers manage patients by using medical devices that collect non-physiological data. By adding new RTM codes and guidance, payers (including Medicare) have opened up new ways to care for your patients and generate recurring revenue streams.

EllieGrid is a smart pill organizer that not only helps increase medication adherence, but also allows doctors and non-physician practitioners to provide effective RTM services.

How It Works

Step 1:

Identify eligible patients (Medicare and Medicare Advantage)

Step 2:

Provide the patient with an EllieGrid or EllieBox

Step 3:

Provide us with the patient's email so we can identify their account

Step 4:

We send you reports of the patients adherence data

Step 5:

Use reports to identify at-risk patients & reach out

Step 6:

Submit the RTM codes for reimbursement

Step 1:

Identify eligible patients (Medicare Advantage, Part-B)

Step 2:

Provide the patient with an EllieGrid or EllieBox

Step 3:

Provide us with the contact of your patient or caregiver

Step 4:

We send you reports of the patients adherence data

Step 5:

Use reports to identify at-risk patients & reach out

Step 6:

Submit the appropriate RTM codes for reimbursement

RTM Codes

(~$19) CPT# 98975
Setup and patient education on use of equipment.

(~$54/monthly) CPT# 98976 (Respiratory), # 98977 (Musculoskeletal), or #989X6 (Cognitive Behavioral)
Data Collection

(~$49/monthly) CPT# 98980
1st 20 minutes of communication with the patient

(~$40/monthly) CPT# 98981
Each additional 20 minutes of communication with patient

How to Set up EllieGrid (Tutorial)

Contact Us

Support@EllieGrid.com

API Access

Integrate EllieGrid with your internal applications

Compliance Reports

Medication Schedule

Entire Medication List

Customizable Alerts

Compliance Reports

Medication Schedule

Entire Medication List

Customizable Alerts

Which Clinical Trial?

EllieGrid is a good fit for trials with the following criteria:

Daily dosing is required

Participants take more than just the IP

Participants are <75 years old

It’s important to have high compliance rates